OUR 5 AREAS OF FOCUS
Creating the International CBD Pipeline
Introduced to investors in March of 2009, Medical Marijuana, Inc. is the first company entirely within the cannabis business space to be traded on public stock markets.
Being traded publicly on the stock exchange is a milestone for any new industry and serves to normalize cannabis as an industry. The creation of Medical Marijuana, Inc. was featured in the CNBC documentary Marijuana, Inc., the most watched program in station history.
Dealing exclusively in cannabis brands, Medical Marijuana, Inc.’s original role in the industry was setting up turn-key medical marijuana dispensaries through their licensing model. Now as an investment firm with holdings in CBD supplement brands, cannabis industry services, and phytocannabinoid research firms, Medical Marijuana, Inc. has positioned their portfolio to be on the front lines of the cannabis revolution in this country.
With over 200,000 current shareholders, the widespread public investment in our company is a show of support for Medical Marijuana, Inc. and the cannabis industry at large.
With over 200,000 current shareholders, the widespread public investment in our company is a show of support for Medical Marijuana, Inc. and the cannabis industry at large. Such boundless support from our investors legitimizes cannabis as a business and confirms Medical Marijuana, Inc. as a shaper of the modern licensing model.
Organizing the volume of capital raised from investors into the cannabis industry also helps make genuine progress possible, through the development of new cannabinoid-based drugs, the opening of new foreign markets, and the creation of innovative CBD hemp oil products, and has allowed us to complete the rest of the ‘firsts’ that follow in this list.